The pharmaceutical industry in the United States is experiencing a rapid surge in requirement for Tirzepatide APIs. This potent medication, used to treat insulin resistance, has gained considerable attention from both consumers and medical practitioners. As a result, numerous companies have emerged as suppliers of Tirzepatide APIs in the USA. We